Negative Effects on Family Functioning From Psychosocial Treatments: A Recommendation for Expanded Safety Monitoring

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Whereas biomedical products are required to be tested for safety with respect to vulnerable organ systems, psychosocial treatments are not required to be tested for safety with respect to vulnerable social systems such as the family. This article provides some evidence for the need to document the potential negative effects of psychosocial treatments on family-level outcomes. Three randomized controlled trials are reviewed in which independent ratings or self-reports of family functioning were measured. Each of the 3 studies compared the efficacy of a family and a nonfamily treatment. Totally unexpectedly, the nonfamily treatment in each of the 3 trials demonstrated significant declines in family functioning. The authors suggest that psychosocial treatments with vulnerable populations have the potential to produce negative side effects on families. Therefore, it is important to conduct further research to determine whether safety studies should be required for psychosocial treatments.

Original languageEnglish
Pages (from-to)468-478
Number of pages11
JournalJournal of Family Psychology
Volume21
Issue number3
DOIs
StatePublished - Sep 1 2007

Fingerprint

Safety
Therapeutics
Vulnerable Populations
Self Report
Randomized Controlled Trials
Research

Keywords

  • deterioration
  • family functioning
  • negative effects
  • psychosocial treatments
  • risk-benefit ratio

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Psychology(all)

Cite this

@article{d9707721b9c1447daea2bf491f7c3577,
title = "Negative Effects on Family Functioning From Psychosocial Treatments: A Recommendation for Expanded Safety Monitoring",
abstract = "Whereas biomedical products are required to be tested for safety with respect to vulnerable organ systems, psychosocial treatments are not required to be tested for safety with respect to vulnerable social systems such as the family. This article provides some evidence for the need to document the potential negative effects of psychosocial treatments on family-level outcomes. Three randomized controlled trials are reviewed in which independent ratings or self-reports of family functioning were measured. Each of the 3 studies compared the efficacy of a family and a nonfamily treatment. Totally unexpectedly, the nonfamily treatment in each of the 3 trials demonstrated significant declines in family functioning. The authors suggest that psychosocial treatments with vulnerable populations have the potential to produce negative side effects on families. Therefore, it is important to conduct further research to determine whether safety studies should be required for psychosocial treatments.",
keywords = "deterioration, family functioning, negative effects, psychosocial treatments, risk-benefit ratio",
author = "Jose Szapocznik and Prado, {Guillermo J}",
year = "2007",
month = "9",
day = "1",
doi = "10.1037/0893-3200.21.3.468",
language = "English",
volume = "21",
pages = "468--478",
journal = "Journal of Family Psychology",
issn = "0893-3200",
publisher = "American Psychological Association Inc.",
number = "3",

}

TY - JOUR

T1 - Negative Effects on Family Functioning From Psychosocial Treatments

T2 - A Recommendation for Expanded Safety Monitoring

AU - Szapocznik, Jose

AU - Prado, Guillermo J

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Whereas biomedical products are required to be tested for safety with respect to vulnerable organ systems, psychosocial treatments are not required to be tested for safety with respect to vulnerable social systems such as the family. This article provides some evidence for the need to document the potential negative effects of psychosocial treatments on family-level outcomes. Three randomized controlled trials are reviewed in which independent ratings or self-reports of family functioning were measured. Each of the 3 studies compared the efficacy of a family and a nonfamily treatment. Totally unexpectedly, the nonfamily treatment in each of the 3 trials demonstrated significant declines in family functioning. The authors suggest that psychosocial treatments with vulnerable populations have the potential to produce negative side effects on families. Therefore, it is important to conduct further research to determine whether safety studies should be required for psychosocial treatments.

AB - Whereas biomedical products are required to be tested for safety with respect to vulnerable organ systems, psychosocial treatments are not required to be tested for safety with respect to vulnerable social systems such as the family. This article provides some evidence for the need to document the potential negative effects of psychosocial treatments on family-level outcomes. Three randomized controlled trials are reviewed in which independent ratings or self-reports of family functioning were measured. Each of the 3 studies compared the efficacy of a family and a nonfamily treatment. Totally unexpectedly, the nonfamily treatment in each of the 3 trials demonstrated significant declines in family functioning. The authors suggest that psychosocial treatments with vulnerable populations have the potential to produce negative side effects on families. Therefore, it is important to conduct further research to determine whether safety studies should be required for psychosocial treatments.

KW - deterioration

KW - family functioning

KW - negative effects

KW - psychosocial treatments

KW - risk-benefit ratio

UR - http://www.scopus.com/inward/record.url?scp=34748907168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748907168&partnerID=8YFLogxK

U2 - 10.1037/0893-3200.21.3.468

DO - 10.1037/0893-3200.21.3.468

M3 - Article

C2 - 17874932

AN - SCOPUS:34748907168

VL - 21

SP - 468

EP - 478

JO - Journal of Family Psychology

JF - Journal of Family Psychology

SN - 0893-3200

IS - 3

ER -